This book highlights the importance of understanding gastric and colon cancer metabolism in guiding diagnosis and drug discovery. It summarizes the correlation between adiponectin and matrix metalloproteinase with colorectal cancer. The book also evaluates the divergent role of hypoxia-inducible factor 1 in colorectal cancer growth and metastasis. After discussing the role of genetic polymorphisms in alcohol metabolizing enzymes and EPHX1 with the onset of colorectal cancer, it reviews the molecular mechanisms of chemoresistance in gastric cancer and novel therapeutic strategies to reverse the chemoresistance of tumors. In addition, the book explores the theranostic role of nanoparticles and therapeutic potential of phytochemicals with regard to colorectal cancer. Given its scope, the book offers a valuable guide for oncologists, academic researchers, pharmaceuticals practitioners, and students who are involved in research and treatment of cancer.Product details Publisher: Springer; 1st ed. 2020 edition (March 4, 2020) Publication Date: March 4, 2020
Theranostics Approaches to Gastric and Colon Cancer (Diagnostics and Therapeutic Advances in GI Malignancies)
$51.59
Be the first to review “Theranostics Approaches to Gastric and Colon Cancer (Diagnostics and Therapeutic Advances in GI Malignancies)” Cancel reply
Related products
$28.99
Ebook New zetlly
$18.99
$16.99
Ebook New zetlly
$22.99
Ebook New zetlly
The Oxford Handbook of the History of Communism (Oxford Handbooks)
$38.99
Ebook New zetlly
Russia, NATO and Cooperative Security: Bridging the Gap (Contemporary Security Studies)
$22.99
Ebook New zetlly
$22.99


Reviews
There are no reviews yet.